Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release
- Author
- TRIVEDI, Madhukar H1 ; DUNNER, David L2 ; GELENBERG, Alan12 ; KORNSTEIN, Susan G3 ; THASE, Michael E4 ; ZAJECKA, John M5 ; ROTHSCHILD, Anthony J6 7 ; FRIEDMAN, Edward S8 ; SHELTON, Richard C9 ; KELLER, Martin B10 ; KOCSIS, James H11
[1] University of Texas Southwestern Medical School, Dallas, Texas, United States
[2] Center for Anxiety and Depression, Mercer Island, Washington, United States
[3] Virginia Commonwealth University, Richmond, Virginia, United States
[4] University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
[5] Rush University Medical Center, Chicago, Illinois, United States
[6] University of Massachusetts Medical School, Worcester, Massachusetts, United States
[7] UMass Memorial Health Care, Worcester, Massachusetts, United States
[8] University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
[9] Vanderbilt University, Nashville, Tennessee, United States
[10] Brown University, Providence, Rhode Island, United States
[11] Weill Cornell Medical College, New York, New York, United States
[12] Heaitticare Technology Systems, Madison, Wisconsin, United States - Source
Journal of affective disorders. 2010, Vol 126, Num 3, pp 420-429, 10 p ; ref : 3/4 p
- CODEN
- JADID7
- ISSN
- 0165-0327
- Scientific domain
- Cognition; Psychology, psychopathology, psychiatry
- Publisher
- Elsevier, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Maintenance treatment Major depressive disorder Psychosocial outcomes Venlafaxine extended release
- Keyword (fr)
- Antidépresseur Etat dépressif Facteur psychosocial Forme libération contrôlée Forme pharmaceutique Homme Psychotrope Récidive Traitement entretien Venlafaxine Catécholamine Inhibiteur recapture Neurotransmetteur Noradrénaline Phénéthylamine dérivé Sérotonine Trouble de l'humeur
- Keyword (en)
- Antidepressant agent Depression Psychosocial factor Controlled release form Dosage form Human Psychotropic Relapse Maintenance treatment Venlafaxine Catecholamine Reuptake inhibitor Neurotransmitter Norepinephrine Phénéthylamine derivatives Serotonin Mood disorder
- Keyword (es)
- Antidepresor Estado depresivo Factor sicosocial Forma liberación controlada Forma farmacéutica Hombre Psicotropo Recaida Tratamiento sostén Venlafaxina Catecolamina Inhibidor recaptura Neurotransmisor Noradrenalina Fenetilamina derivado Serotonina Trastorno humor
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07A Depression
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G01 Depression
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer…
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 23377806
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.jad.2010.04.011 
https://dx.doi.org/10.1016/j.jad.2010.04.011
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.jad.2010.04.011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Journal of affective disorders\";s:9:\"\u0000*\u0000stitle\";s:17:\"J. affect. disord\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"429\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0165-0327\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TRIVEDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Madhukar H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"DUNNER, David L\";i:1;s:15:\"GELENBERG, Alan\";i:2;s:18:\"KORNSTEIN, Susan G\";i:3;s:16:\"THASE, Michael E\";i:4;s:15:\"ZAJECKA, John M\";i:5;s:21:\"ROTHSCHILD, Anthony J\";i:6;s:18:\"FRIEDMAN, Edward S\";i:7;s:18:\"SHELTON, Richard C\";i:8;s:16:\"KELLER, Martin B\";i:9;s:15:\"KOCSIS, James H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JADID7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.jad.2010.04.011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Journal of affective disorders\";s:9:\"\u0000*\u0000stitle\";s:17:\"J. affect. disord\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"429\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0165-0327\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TRIVEDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Madhukar H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"DUNNER, David L\";i:1;s:15:\"GELENBERG, Alan\";i:2;s:18:\"KORNSTEIN, Susan G\";i:3;s:16:\"THASE, Michael E\";i:4;s:15:\"ZAJECKA, John M\";i:5;s:21:\"ROTHSCHILD, Anthony J\";i:6;s:18:\"FRIEDMAN, Edward S\";i:7;s:18:\"SHELTON, Richard C\";i:8;s:16:\"KELLER, Martin B\";i:9;s:15:\"KOCSIS, James H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JADID7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.jad.2010.04.011\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.jad.2010.04.011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Journal of affective disorders\";s:9:\"\u0000*\u0000stitle\";s:17:\"J. affect. disord\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"429\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0165-0327\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TRIVEDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Madhukar H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"DUNNER, David L\";i:1;s:15:\"GELENBERG, Alan\";i:2;s:18:\"KORNSTEIN, Susan G\";i:3;s:16:\"THASE, Michael E\";i:4;s:15:\"ZAJECKA, John M\";i:5;s:21:\"ROTHSCHILD, Anthony J\";i:6;s:18:\"FRIEDMAN, Edward S\";i:7;s:18:\"SHELTON, Richard C\";i:8;s:16:\"KELLER, Martin B\";i:9;s:15:\"KOCSIS, James H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JADID7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.jad.2010.04.011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Journal of affective disorders\";s:9:\"\u0000*\u0000stitle\";s:17:\"J. affect. disord\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"429\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0165-0327\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TRIVEDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Madhukar H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"DUNNER, David L\";i:1;s:15:\"GELENBERG, Alan\";i:2;s:18:\"KORNSTEIN, Susan G\";i:3;s:16:\"THASE, Michael E\";i:4;s:15:\"ZAJECKA, John M\";i:5;s:21:\"ROTHSCHILD, Anthony J\";i:6;s:18:\"FRIEDMAN, Edward S\";i:7;s:18:\"SHELTON, Richard C\";i:8;s:16:\"KELLER, Martin B\";i:9;s:15:\"KOCSIS, James H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JADID7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.jad.2010.04.011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Journal of affective disorders\";s:9:\"\u0000*\u0000stitle\";s:17:\"J. affect. disord\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"126\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"420\";s:8:\"\u0000*\u0000epage\";s:3:\"429\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0165-0327\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TRIVEDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Madhukar H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"DUNNER, David L\";i:1;s:15:\"GELENBERG, Alan\";i:2;s:18:\"KORNSTEIN, Susan G\";i:3;s:16:\"THASE, Michael E\";i:4;s:15:\"ZAJECKA, John M\";i:5;s:21:\"ROTHSCHILD, Anthony J\";i:6;s:18:\"FRIEDMAN, Edward S\";i:7;s:18:\"SHELTON, Richard C\";i:8;s:16:\"KELLER, Martin B\";i:9;s:15:\"KOCSIS, James H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JADID7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
